PMID- 36846431
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230228
IS  - 2378-8038 (Print)
IS  - 2378-8038 (Electronic)
IS  - 2378-8038 (Linking)
VI  - 8
IP  - 1
DP  - 2023 Feb
TI  - Patient reported outcome measures: The impact of environment on VHI-10 responses.
PG  - 150-155
LID - 10.1002/lio2.1016 [doi]
AB  - OBJECTIVE: A key outcome measure in the clinical evaluation of dysphonia is the 
      Voice Handicap Index (VHI-10). The clinical validity of the VHI-10 was 
      established from surveys administered in the physician's office. We aim to 
      understand whether VHI-10 responses remain reliable when the questionnaire is 
      completed in settings other than the physician's office. METHODS: This is a 
      prospective observational study conducted over a 3-month period in the outpatient 
      laryngology setting. Thirty-five adult patients presenting with a complaint of 
      dysphonia, which was symptomatically stable for the preceding 3 months, were 
      identified. Each patient completed a VHI-10 survey during the initial office 
      visit, followed by three weekly out-of-office (termed "ambulatory") VHI-10 
      surveys, over the course of 12 weeks. The specific setting in which the patient 
      completed the survey was recorded (social, home, or work). The Minimal Clinically 
      Important Difference (MCID) is defined as 6 points based on existing literature. 
      T-tests and a test of one proportion were used for analysis. RESULTS: A total of 
      553 responses were collected. Of these, 347 ambulatory scores (63%) differed from 
      the Office score by at least the MCID. Specifically, 94 (27%) were higher than 
      the in-office score by 6 or more points while 253 (73%) were lower. CONCLUSION: 
      The setting in which the VHI-10 is completed affects how the patient answers the 
      questions. The score is dynamic, reflecting effects of the patients' environment 
      during completion. Utilization of VHI-10 scores to measure clinical treatment 
      response is only valid if each response is obtained in the same setting. LEVEL OF 
      EVIDENCE: 4.
CI  - (c) 2023 The Authors. Laryngoscope Investigative Otolaryngology published by Wiley 
      Periodicals LLC on behalf of The Triological Society.
FAU - Kinberg, Eliezer C
AU  - Kinberg EC
AUID- ORCID: 0000-0001-5954-0237
AD  - Department of Otolaryngology-Head and Neck Surgery Icahn School of Medicine at 
      Mount Sinai New York New York USA.
FAU - Taree, Amir
AU  - Taree A
AUID- ORCID: 0000-0003-4960-9709
AD  - Icahn School of Medicine at Mount Sinai New York New York USA.
FAU - Gray, Mingyang
AU  - Gray M
AUID- ORCID: 0000-0002-1146-9942
AD  - Department of Otolaryngology-Head and Neck Surgery Icahn School of Medicine at 
      Mount Sinai New York New York USA.
FAU - Filip, Peter
AU  - Filip P
AUID- ORCID: 0000-0002-6898-6633
AD  - Department of Otolaryngology-Head and Neck Surgery Icahn School of Medicine at 
      Mount Sinai New York New York USA.
FAU - Courey, Mark
AU  - Courey M
AUID- ORCID: 0000-0001-6885-2929
AD  - Department of Otolaryngology-Head and Neck Surgery Icahn School of Medicine at 
      Mount Sinai New York New York USA.
LA  - eng
PT  - Journal Article
DEP - 20230130
PL  - United States
TA  - Laryngoscope Investig Otolaryngol
JT  - Laryngoscope investigative otolaryngology
JID - 101684963
PMC - PMC9948561
OTO - NOTNLM
OT  - outcomes/cost effectiveness
OT  - voice disorders
OT  - voice/dysphonia
COIS- The authors have no financial interests or conflicts of interests to disclose.
EDAT- 2023/02/28 06:00
MHDA- 2023/02/28 06:01
PMCR- 2023/01/30
CRDT- 2023/02/27 05:51
PHST- 2022/10/12 00:00 [received]
PHST- 2022/12/30 00:00 [revised]
PHST- 2023/01/08 00:00 [accepted]
PHST- 2023/02/27 05:51 [entrez]
PHST- 2023/02/28 06:00 [pubmed]
PHST- 2023/02/28 06:01 [medline]
PHST- 2023/01/30 00:00 [pmc-release]
AID - LIO21016 [pii]
AID - 10.1002/lio2.1016 [doi]
PST - epublish
SO  - Laryngoscope Investig Otolaryngol. 2023 Jan 30;8(1):150-155. doi: 
      10.1002/lio2.1016. eCollection 2023 Feb.